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ﺍﻟﻤﻠﺨﺺ
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Abstract
Objective: To evaluate the predictive value of oestradiol
levels on the day of human chorionic gonadotrophin
(hCG) administration on intrauterine insemination success
rate.
Methods: The present study included 206 intrauterine
insemination (IUI) cycles performed between June 2011
and October 2012. All IUI cycles were preceded by ovarian
stimulation with gonadotrophins starting on cycle day 3. A
single IUI was performed 24–36 h after hCG administra-
tion. Binary logistic regression analysis was performed to
define the covariates of IUI success. The main outcome
measure, clinical pregnancy rate per cycle, was assessed
according to the oestradiol level.
Results: With LR+=2 and AUC= 0.73, ROC analysis
revealed out the oestradiol level as 465 pg/mL to predict
the pregnancy with 60% sensitivity and 66% specificity.
Binary logistic regression analysis identified the presence
of oestradiol levels higher than 465 pg/mL (p< 0.01, 95%
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CI = 0.147–0.687) and stimulation duration (p< 0.01,
95% CI = 0.201–0.705) as the covariates approached sta-
tistical significance for IUI success.
Conclusions: Oestradiol level >465 pg/mL on the day of
hCG administration might point out advanced outcome
on mild ovarian stimulation combined with insemination.
Keywords: Intrauterine insemination; Oestradiol level; Out-
come; Pregnancy rate
 2014 Taibah University. Production and hosting by Elsevier
Ltd. All rights reserved.
Z.S. Ozkan et al. 37if the woman had at least one patent fallopian tube and a doc-
umented normal endometrial cavity.
A transvaginal ultrasound scan was performed on cycle
day 3. On the same day, ovarian stimulation was performed
with recombinant FSH (rFSH; Gonal-F, Merck Serono,
Istanbul, Turkey; or Puregon, MSD, Istanbul, Turkey) at a
starting dose of 75 IU/day. If the patient’s body mass index
(BMI) was P25 kg/m2, the starting dose of rFSH was in-
creased to 100 IU/day. The ovarian response and endometrial
thickness were monitored by transvaginal ultrasonography
first on day 7 of stimulation and then on alternate days;
the rFSH dose was adjusted according to the ovarian re-
sponse. When the average diameter of the leading follicle
reached P16 mm, 250 lg of recombinant human chorionic
gonadotropin (hCG, Ovitrelle, Merck Serono, Istanbul, Tur-
key) was administered, and endometrial thickness and oestra-
diol levels were evaluated.
A single IUI was performed 24–36 h after hCG injection.
The semen samples used for insemination were processed with-
in 1 h of ejaculation by density gradient centrifugation, fol-
lowed by washing with culture medium. The women rested
for 15 min after IUI. Luteal phase support was given to all wo-
men with 90 mg daily of vaginal micronized 8% progesterone
gel. When there were four or more follicles with a diameter
P16 mm or a serum oestradiol level >1500 pg/ml, hCG
administration was stopped, and regular coitus was forbidden
to avoid multiple pregnancy.
Statistical analysis
Statistical analysis was performed with SPSS version 16.0. The
main outcome measure was CPR per cycle. Clinical pregnancy
was defined as the evidence of pregnancy by ultrasound exam-
ination of the gestational sac at weeks 5–7. To predict the out-
come, female age, duration of infertility, baseline FSH level,
baseline luteinizing hormone level, baseline oestradiol level, to-
tal rFSH dose, stimulation duration and total motile sperm
count were included in the calculations. Descriptive statistics
were presented as percentages or the mean ± standard devia-
tion. Differences between groups for categorical variables were
analysed by the Chi-square test or Fisher’s exact test, as appro-
priate, and comparisons of continuous variables between
groups were analysed with the Student’s t test according to
the results of normality tests. Binary logistic regression analy-
sis was used to analyse oestradiol level on the day of hCG
administration, dominant follicle count, duration of stimula-
tion, total motile sperm count before and after washing,
BMI, previous pelvic surgery and insemination time, in order
to identify the covariates that were significantly associated
with successful IUI. Receiver operating characteristic (ROC)
analysis was performed to determine the area under the curve
and the likelihood ratio that showed the oestradiol level pre-
dicted pregnancy. P values <0.05 were considered statistically
significant.
Results
The overall CPR of the cohort was 16.8% per cycle. The demo-
graphic and clinical characteristics of the women are presented
in Table 1 and the stimulation and insemination parameters of
the couples in Table 2. With a likelihood ratio of 2 and an areaIntroduction
Intrauterine insemination (IUI) is widely used to treat
unexplained infertility and male subfertility. It is generally con-
sidered to be an intermediate step before assisted reproductive
techniques such as in vitro fertilization with or without intra-
cytoplasmic sperm injection.1 The success rate of IUI is still
a subject of controversy, with a 10–20% clinical pregnancy
rate (CPR) expected per cycle.2,3 IUI combined with controlled
ovarian stimulation may increase the cumulative pregnancy
rate,4 and the low CPRs seen are often attributed to the use
of mild stimulation protocols for a monofollicular response.5
Aggressive protocols with higher doses of gonadotrophins im-
prove pregnancy rates by increasing the number of preovula-
tory follicles and the rate of multiple pregnancy.6 The aim of
our study was to determine a cut-off value for the oestradiol
level that predicts the insemination outcome after mild ovarian
stimulation.
Materials and Methods
The population studied consisted of 206 womenwho underwent
ovulation induction with IUI between June 2011 and October
2012. The inclusion criteria were failure to conceive for
P12 months of unprotected intercourse, age <38 years, basal
follicle-stimulating hormone (FSH) level <12 IU/l and total
motile sperm count of the partner>5 million. The exclusion cri-
teria were ovarian cysts >15 mm on a baseline transvaginal
ultrasound scan, severe endometriosis (stage III or IV according
to the revisedAmerican Fertility Society staging), the total num-
ber of motile sperm<5 million, any contraindication for one of
the ovarian stimulation drugs and multiple pregnancy.
All the couples had undergone a standard infertility evalu-
ation that included medical history, physical examination,
assessment of tubal patency by either hysterosalpingography
or laparoscopy, basal FSH, luteinizing hormone, oestradiol,
thyroid-stimulating hormone, prolactin evaluation on cycle
day 3 and a semen analysis. Abnormal semen results were con-
firmed by a second analysis P3 weeks apart. Semen samples
with a concentration of >20 million/ml, progressive motility
>50% and normal morphology >14% were considered nor-
mal.7,8 The motility categories were classified as grade A (rapid
linear with sluggish progressive motility), grade B (nonprogres-
sive motility) and grade C (immotility). Semen analyses that
failed to meet these criteria but with a total motile sperm count
of >5 million were included. Couples were considered eligible
under the curve of 0.73, ROC analysis showed an oestradiol le-
vel of 465 pg/ml predicted pregnancy with 60% sensitivity and
66% specificity. In a comparison of the ovarian stimulation and
insemination parameters of couples according to an oestradiol
level <465 pg/ml vs >465 pg/ml, significant differences were
found for dominant follicle count (1.1 ± 0.3 vs 2.3 ± 0.9,
p< 0.01) and CPR (12.4% vs 23.9%, p= 0.04) (Table 3).
Oestradiol level on the day of hCG administration, dominant
follicle count, BMI, duration of stimulation and previous pelvic
surgery were statistically significant (p< 0.01) in a regression
model (Table 4). A comparison of CPR according to a domi-
nant follicle count of 1 (10.9%) and >1 (27.3%) showed a sig-
nificant difference (p= 0.002). No significant difference in
CPR was found according to duration of stimulation.
Discussion
The results obtained show significantly higher CPRs in pa-
tients undergoing controlled ovarian stimulation with IUI with
oestradiol levels >465 pg/ml and among women with two or
three dominant follicles than among those with one. The over-
all CPR in the present study was 16.8%, consistent with the
IUI success rate reported in other studies.3,9,10 Our results con-
firm those of other studies of ovarian stimulation with gonad-
otrophins combined with IUI, with a greater probability of
conception in unexplained infertility and male subfertility.11,12
Other studies have shown that the timing of insemination
during the periovulatory period is important in order to pro-
vide sperm that are capable of fertilizing the oocyte, and sched-
uling IUI at different times has been studied. Improved
Table 2: Type of ovarian stimulation and insemination (mean
± standard deviation).
Gonadotrophin dose (IU)
Starting 99 ± 64
Final 105 ± 60
Total 905 ± 567
Stimulation duration (days) 9.4 ± 3.6
Motile sperm count (106)
Total 113 ± 106
After washing 90 ± 84
Oestradiol level on day 3 of hCG
administration (pg/ml)
506 ± 410
Endometrial thickness on day of hCG
administration (mm)
9.2 ± 1.4
Dominant follicle count 1.5 ± 0.8
Insemination time after hCG
administration (h)
24 33 (15.9%)
36 173 (83.2%)
Clinical pregnancy rate per cycle 35/206 (16.8%)
hCG, human chorionic gonadotrophin.
Table 4: Factors that influence the success of insemination.
Factor Odds ratio 95% CI p Value
Oestradiol level on day of
hCG administration
0.31 0.147–0.687 <0.01
Dominant follicle count 0.12 0.070–0.212 <0.01
Stimulation duration 0.37 0.201–0.705 <0.01
Body mass index 0.17 0.113–0.259 <0.01
Pelvic surgery 0.23 0.156–0.346 <0.01
Total motile sperm count 0.23 0.225–1.443 0.23
Total motile sperm count
after washing
0.26 0.143–0.501 <0.01
Insemination time 0.41 0.134–1.270 0.12
hCG, human chorionic gonadotrophin.
Table 3: Main characteristics of couples according to oestradiol
level on day of administration of human chorionic gonadotrophin.
Characteristic Oestradiol (pg/ml) p Value
<465
(n= 113)
>465
(n= 93)
Female age (years) 29 ± 4.6 29.8 ± 5.3 0.33
Infertility duration (months) 51.6 ± 34.8 55 ± 46.9 0.57
Body mass index (kg/m2) 25.1 ± 4.4 24 ± 3.9 0.10
Day 3 FSH (mIU/ml) 6.5 ± 4.3 5.5 ± 2.1 0.07
Day 3 luteinizing
hormone (mIU/ml)
5.7 ± 4.7 6.2 ± 4.0 0.48
Day 3 oestradiol (pg/ml) 53.3 ± 35.1 53.2 ± 38.4 0.99
Motile sperm count (106)
Total 109.9 ± 102.5 116.7 ± 100.5 0.67
After washing 97.5 ± 75.7 101.8 ± 78.9 0.77
Total motility (%) 66.6 ± 15 68.5 ± 16.9 0.44
Stimulation duration (days) 9.6 ± 3.2 9.6 ± 4.5 0.93
Endometrial thickness (mm) 8.4 ± 1.6 9.5 ± 1 0.05
Dominant follicle count 1.1 ± 0.3 2.3 ± 0.9 <0.01
Clinical pregnancy rate (%) 12.4 23.9 0.04
FSH, follicle-stimulating hormone.
Table 1: Demographic and baseline characteristics of 206 women
who underwent ovulation induction with intrauterine insemination
(mean ± standard deviation).
Age (years) 29.3 ± 4.9
Infertility duration (months) 53.9 ± 41
Infertility type
Primary 145 (69.7%)
Secondary 63 (30.3%)
Body mass index (kg/m2) 24.8 ± 4.3
Day 3 FSH (IU/ml) 6.2 ± 3.5
Day 3 luteinizing hormone (IU/ml) 5.7 ± 4.2
Day 3 oestradiol (IU/ml) 54.2 ± 37.1
Prolactin (IU/ml) 13.3 ± 8.3
Thyroid-stimulating hormone (IU/ml) 1.7 ± 3.1
Ovarian reserve (antral follicle count)
<10 107 (51.4%)
10–20 43 (20.7%)
>20 58 (27.9%)
Menstrual cycle
Regular 152 (73.1%)
Oligomenorrhea 51 (24.5%)
Menometrorrhagia 5 (2.4%)
Tubal patency
Unilateral 25 (12%)
Bilateral 181 (88%)
38 Estradiol and insemination
bined with IUI.28 In another study, however, the authors re-
ported that the CPR was not affected by the number of
follicles present at the time of intrauterine insemination or
the serum oestradiol level on the day of hCG administration
in a controlled cycle of ovarian hyperstimulation in non-andro-
logic, non-peritubal factor infertility, although there was a clear
trend towards higher pregnancy rates with more follicles.29
Researchers investigated either hCG application is better
before IUI or after IUI on 100 couples. The comparison of fer-
tility rate showed no difference for different timing of hCG
injections. But interestingly, the women with a history of more
than 6 years of infertility had significantly higher pregnancy
rate (81.82%) than the women with a history of infertility
shorter than 6 years (18.18%).30 In another study it was re-
ported that there was no difference in simultaneous use of
hCG injection compared to cycles in which IUI was performed
34–36 h after hCG injection.31 Soria et al. reported the highest
pregnancy rates in cases with shorter infertility duration,
BMIP 25 kg/m2, FSH< 9 IU/L, anovulation due to polycys-
tic ovary syndrome, at least two follicles recruited through con-
trolled ovarian hyperstimulation during IUI cycle.32 Jeon et al.
reported the unfavourable factors to predict clinical pregnancy
during the first IUI cycles as follows: women older than 39 years
(OR: 0.263, 95% CI: 0.076–0.906, p= 0.034), longer duration
of infertility (OR: 0.967, 95% CI: 0.942–0.993, p= 0.012),
endometriosis vs unexplained infertility (OR: 0.177, 95% CI:
0.040–0.775, p= 0.022) and endometrial thickness below
7 mm (OR: 0.114, 95% CI: 0.015–0.862, p= 0.035).33
The limitations of this study include the fact that our study
population had both unexplained infertility and male subfertil-
ity. Such heterogeneity could be avoided by recruiting a study
population with only unexplained infertility. Secondly, the
study population was small.
Conclusion
In conclusion, IUI is a useful, cost-effective treatment for some
causes of infertility. While female age and severe male factors
negatively affect the success of IUI, unexplained and anovula-
tory infertility can be treated successfully. The serum oestra-
diol level on the day of hCG administration is predictive of
a positive outcome, a level <465 pg/ml indicating a poor out-
come of mild ovarian stimulation combined with insemination.
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